The potential and challenges of mucosal COVID-19 vaccines

by

In November 2022, the National Institute of Allergy and Infectious Diseases (NIAID) co-hosted a virtual workshop on the importance and challenges of developing mucosal vaccines for SARS-COV-2. The highlights of this workshop have now been published as a report in npj Vaccines.

Leave A Comment

Your email address will not be published. Required fields are marked *